Personalis (PSNL) Cash from Investing Activities Growth (3y) (2021 - 2026)
Personalis (PSNL) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 139.73 Bn | 135.38 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 45.88 Bn | 45.68 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.62 Bn | 37.81 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.28 Bn | 37.20 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.50 Bn | 37.40 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 29.82 Bn | 28.65 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.14 Bn | 25.52 Bn | 1.03 Bn | 41.86% |
| 10 | Personalis | 1.41 Bn | 1.17 Bn | 281,000.00 | -74.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.74% |
| Dec 31, 2025 | -38.52% |
| Sep 30, 2025 | 20.04% |
| Jun 30, 2025 | -29.86% |
| Mar 31, 2025 | -92.48% |
| Dec 31, 2024 | -38.49% |
| Sep 30, 2024 | -43.42% |
| Jun 30, 2024 | 31.54% |
| Mar 31, 2024 | 27.58% |
| Dec 31, 2023 | 43.09% |
| Sep 30, 2023 | -52.17% |
| Jun 30, 2023 | 65.91% |
| Mar 31, 2023 | 634.40% |
| Dec 31, 2022 | 37.98% |
| Sep 30, 2022 | 30.97% |
| Jun 30, 2022 | 143.88% |
| Mar 31, 2022 | -48.77% |
| Dec 31, 2021 | 294.68% |
| Sep 30, 2021 | 158.44% |